French Pasteur Institute study shows how well Ivermectin can treat COVID-19 infection


LifeSite News: July 19, 2021 Ivermectin (IVM) attenuates COVID-19 inflammation and other clinical symptoms in animals infected with SARS-CoV-2, according to a recent study by the French Pasteur Institute.

“And ye shall know the truth, and the truth shall make you free.” John 8:23 KJV

The paper was published in EMBO Molecular Medicine last Monday and states clearly that “standard doses” of Ivermectin can prevent clinical deterioration and reduce olfactory deficit. The abstract noted: “Altogether, this study supports the use of immunomodulatory drugs such as IVM, to improve the clinical condition of SARS-CoV-2-infected patients.”

In a normal world the Pasteur Institute’s study would mark a turning point in the COVID-19 crisis, relativizing the “vaccine” narrative. It is remarkable that the study was published on the very day that French president Emmanuel Macron announced what amounts to mandatory vaccination for the entire population aged 12 and over: compulsory vaccination of all healthcare workers and members of related professions, and a universal COVID passport that would require testing every two days for those who refuse the jab to be able to live normally – with a 10,000 euro fine for individuals who would try to enter cafés, restaurants, hospitals, homes for the elderly, long-distance trains and coaches, cinemas, shopping centers, and the like. Read More